MRI inflammation, disease activity and functional impairment are more effectively reduced by escalation to biologics compared to CSDMARD-escalation in rheumatoid arthritis patients in clinical remission following a treat-to-target strategy: secondary analyses of the imagine-ra trial

Autor: Signe Moller-Bisgaard, Kim Hørslev-Petersen, Bo Jannik Ejbjerg, Merete Lund Hetland, Christensen, R., Lykke Ornbjerg, Daniel Glinatski, Møllenbach Møller, J., Boesen, M., Kristian Stengaard-Pedersen, Ole Rintek Madsen, Jensen, B., Villadsen, J., Ellen Margrethe Hauge, Philip Bennett, Oliver Hendricks, Asmussen, K., Kowalski, M., Lindegaard, H. M., Henning Bliddal, Steen Krogh, N., Torkell Ellingsen, Nielsen, A., Anne Grethe Jurik, Balding, L., Thomsen, H., Østergaard, M.

Publikováno v: University of Southern Denmark
Moller-Bisgaard, S, Hørslev-Petersen, K, Ejbjerg, B J, Hetland, M L, Christensen, R, Ornbjerg, L, Glinatski, D, Møller, J M, Boesen, M, Stengaard-Pedersen, K, Madsen, O R, Jensen, B, Villadsen, J, Hauge, E M, Bennett, P, Hendricks, O, Asmussen, K, Kowalski, M, Lindegaard, H M, Bliddal, H, Steen Krogh, N, Ellingsen, T J, Nielsen, A, Jurik, A G, Balding, L, Thomsen, H & Østergaard, M 2020, ' MRI inflammation, disease activity and functional impairment are more effectively reduced by escalation to biologics compared to CSDMARD-escalation in rheumatoid arthritis patients in clinical remission following a treat-to-target strategy: secondary analyses of the imagine-ra trial ', Annals of the Rheumatic Diseases, vol. 79, no. Suppl. 1, pp. 577-578 . < https://ard.bmj.com/content/79/Suppl_1/581 >
Møller-Bisgaard, S, Hørslev-Petersen, K, Ejbjerg, B J, Hetland, M L, Christensen, R, Ornbjerg, L, Glinatsi, D, Møller, J M, Boesen, M, Stengaard-Pedersen, K, Madsen, O R, Jensen, B, Villadsen, J, Hauge, E M, Bennett, P, Hendricks, O, Asmussen, K, Kowalski, M, Lindegaard, H M, Bliddal, H, Steen Krogh, N, Ellingsen, T J, Nielsen, A, Jurik, A G, Balding, L, Thomsen, H & Østergaard, M 2020, ' MRI INFLAMMATION, DISEASE ACTIVITY AND FUNCTIONAL IMPAIRMENT ARE MORE EFFECTIVELY REDUCED BY ESCALATION TO BIOLOGICS COMPARED TO CSDMARD-ESCALATION IN RHEUMATOID ARTHRITIS PATIENTS IN CLINICAL REMISSION FOLLOWING A TREAT-TO-TARGET STRATEGY: SECONDARY ANALYSES OF THE IMAGINE-RA TRIAL ', EULAR 2020, 03/06/2020-06/06/2020 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::068cb4256eaae83d90866ff051018b42
https://portal.findresearcher.sdu.dk/en/publications/d62bb874-8fd5-446d-96ef-637212b445fa